Assenagon Asset Management’s Medtronic MDT Stock Holding History

Assenagon Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,500	Closed	-$947K	–	1440
2023 Q4	$947K	Hold	11,500	–	–	﹤0.01%	1110
2023 Q3	$901K	Hold	11,500	–	–	﹤0.01%	1065
2023 Q2	$1.01M	Hold	11,500	–	–	﹤0.01%	967
2023 Q1	$927K	Buy	11,500 +2,500	+28%	+$204K	﹤0.01%	1070
2022 Q4	$699K	Hold	9,000	–	–	﹤0.01%	1116
2022 Q3	$727K	Hold	9,000	–	–	﹤0.01%	1014
2022 Q2	$808K	Hold	9,000	–	–	﹤0.01%	1128
2022 Q1	$999K	Hold	9,000	–	–	﹤0.01%	1050
2021 Q4	$931K	Sell	9,000 -700	-7%	-$81.1K	﹤0.01%	1054
2021 Q3	$1.22M	Hold	9,700	–	–	﹤0.01%	852
2021 Q2	$1.2M	Hold	9,700	–	–	﹤0.01%	881
2021 Q1	$1.15M	Buy	+9,700	New	+$1.14M	﹤0.01%	900

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Assenagon Asset Management's MDT Position: Q2 2026 in Review

Assenagon Asset Management reduced its Medtronic (MDT) stake by 2.4% in Q2 2026, selling an estimated $65.9K and leaving 33,621 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #801.

Assenagon Asset Management first reported a position in MDT in Q1 2018 and has held it in 32 quarters since. The position peaked at $59.5M in Q3 2022. 1,392 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Assenagon Asset Management held 33,621 shares of Medtronic worth $2.63M as of Q2 2026.
Assenagon Asset Management sold 817 Medtronic shares in Q2 2026, an estimated $65.9K.
Medtronic made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #801 holding.
Assenagon Asset Management first reported a position in Medtronic in Q1 2018 and has held it in 32 quarters since.
Assenagon Asset Management's Medtronic position peaked at $59.5M in Q3 2022.
1,392 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.